Supreme Court Dismisses Case About Chemical Abortion Drug Access
Jun 14, 2024
auto_awesome
Pharmacy chains to start selling mifepristone for chemical abortions in some states. Supreme Court decision on access through telehealth and mail order. Debate on safety and regulation of chemical abortions.
Pharmacy chains now dispensing mifepristone for medical abortions, raising concerns about safety measures being eliminated.
Legal actions are vital to regulate and distribute mifepristone, aiming to address safety concerns and protect pre-born lives.
Deep dives
Changes in Access to Mifepristone
The podcast discusses the evolution in access to the drug Mifepristone for medical abortions. Originally requiring in-person appointments and follow-ups, the FDA's actions, starting from the Obama administration through to the Biden administration, have gradually expanded access. Recent developments include allowing retail pharmacies like Walgreens and CVS to dispense the drug. Critics, such as the Alliance for Hippocratic Medicine, argue that these changes endanger women by eliminating safety measures like in-person doctor visits.
Concerns and Advocacy Related to Chemical Abortions
The podcast delves into the safety concerns associated with chemical abortions, particularly focusing on the drug Mifepristone. Despite claims of safety, evidence points to risks for both pre-born babies and mothers. Complications such as heavy bleeding, incomplete abortions, and infections have been linked to the drug. Legal actions and advocacy efforts are highlighted as crucial in addressing the regulation and distribution of Mifepristone, emphasizing the need for legislative action and strategies to protect pre-born lives.
1.
Supreme Court's Dismissal of Case on Mifepristone Access and Abortion Regulations